Drug shortage: Carboplatin Injection (KYXATA, CARBOPLATIN)
FDA lists 35 presentations as Current. Availability: Unavailable (12), Limited Availability (8), Available (9). Reason: Demand increase for the drug; Discontinuation of the manufacture of the drug. Companies: Avyxa Pharma, LLC, Teyro Labs, Ingenus Pharmaceuticals LLC, Accord Healthcare Inc., Gland Pharma Limited….
- Published by source
- 2023-04-28
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-28
Affected
- Manufacturer
- Avyxa Pharma, LLC
- Products
- Carboplatin Injection KYXATA CARBOPLATIN
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-04-28
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #852 | new | 2026-10-22 | 3a3878b52c50…5e437f | e90961260429…96f81d |
| #1130 | update | 2026-10-23 | 47bf262facad…f1e563 | 3175e01df137…358287 |
| #1368 | update | 2026-10-23 | 117b258bd11e…c909c5 | a253f2606a00…7dd893 |
| #2164 | update | 2026-10-27 | d5da3bc24a7e…e8ab6c | d13ba4a924dc…f535ec |
| #2427 | update | 2026-10-27 | 6f3ed45f6469…844172 | 78521e8d5353…24fd63 |
| #2535 | update | 2026-10-28 | 5feac746c1cc…bd9739 | 60dd5057f4de…0a3f52 |
| #2702 | update | 2026-10-28 | 8725c07f12d9…72a966 | 60ad510cb692…4d2e00 |
Chain head: #2800 60b0da2762c7…c27b07